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Summary
Background The Nordic countries have commonalities in gender equality, economy, welfare, and health care, but 
differ in culture and lifestyle, which might create country-wise health differences. This study compared life expectancy, 
disease burden, and risk factors in the Nordic region.
Methods Life expectancy in years and age-standardised rates of overall, cause-specific, and risk factor-specific estimates 
of disability-adjusted life-years (DALYs) were analysed in the Global Burden of Diseases, Injuries, and Risk Factors 
Study (GBD) 2017. Data were extracted for Denmark, Finland, Iceland, Norway, and Sweden (ie, the Nordic countries), 
and Greenland, an autonomous area of Denmark. Estimates were compared with global, high-income region, and 
Nordic regional estimates, including Greenland.
Findings All Nordic countries exceeded the global life expectancy; in 2017, the highest life expectancy was in Iceland 
among females (85·9 years [95% uncertainty interval [UI] 85·5–86·4] vs 75·6 years [75·3–75·9] globally) and Sweden 
among males (80·8 years [80·2–81·4] vs 70·5 years [70·1–70·8] globally). Females (82·7 years [81·9–83·4]) and males 
(78·8 years [78·1–79·5]) in Denmark and males in Finland (78·6 years [77·8–79·2]) had lower life expectancy than in 
the other Nordic countries. The lowest life expectancy in the Nordic region was in Greenland (females 77·2 years 
[76·2–78·0], males 70·8 years [70·3–71·4]). Overall disease burden was lower in the Nordic countries than globally, 
with the lowest age-standardised DALY rates among Swedish males (18 555·7 DALYs [95% UI 15 968·6–21 426·8] 
per 100 000 population vs 35 834·3 DALYs [33 218·2–38 740·7] globally) and Icelandic females (16 074·1 DALYs 
[13 216·4–19 240·8] vs 29 934·6 DALYs [26 981·9–33 211·2] globally). Greenland had substantially higher DALY rates 
(26 666·6 DALYs [23 478·4–30 218·8] among females, 33 101·3 DALYs [30 182·3–36 218·6] among males) than the 
Nordic countries. Country variation was primarily due to differences in causes that largely contributed to DALYs 
through mortality, such as ischaemic heart disease. These causes dominated male disease burden, whereas non-fatal 
causes such as low back pain were important for female disease burden. Smoking and metabolic risk factors were 
high-ranking risk factors across all countries. DALYs attributable to alcohol use and smoking were particularly high 
among the Danes, as was alcohol use among Finnish males.
Interpretation Risk factor differences might drive differences in life expectancy and disease burden that merit 
attention also in high-income settings such as the Nordic countries. Special attention should be given to the high 
disease burden in Greenland.
Funding Bill & Melinda Gates Foundation. The work on this paper was supported by the Research Council of Norway 
through FRIPRO (project number 262030) and by the Norwegian Institute of Public Health.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
The Nordic region consists of the countries Denmark, 
Finland, Iceland, Norway, and Sweden, and three 
smaller autonomous areas of two of the countries: 
Greenland and Faroe Islands (Denmark), and Åland 
Islands (Finland). Altogether, 27·1 million people 
inhabit the region (appendix p 2). The countries have a 
strong tradition of collaboration, and the shared features 
of policy and welfare systems in the region are referred 
to as the Nordic model. Social security for inhabitants is 
the core of the Nordic model, which includes free higher 
education, a social safety net for people with reduced 
health and work capacities, and a universal and 
predominantly publicly financed health-care system. In 
general, the Nordic countries rank highly on a range 
of sociodemographic and health-relevant measures, 
such as the UN Human Development Indices and 
Indicators, gender equality, educational attainment, 
and labour force participation. Furthermore, while they 
are among the countries in the world with the highest 
gross domestic product (GDP) per capita, they are also 
ranked among the countries with lowest income 
disparities within the Organisation for Economic Co-
operation and Development area. However, there are 
also notable diversities between the countries in terms 
of history, societal development, immigration, cultures, 
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and lifestyles. These differences can cause variation in 
disease burden.
The health situation in the Åland Islands and Faroe 
Islands is considered comparable to that of Finland and 
Denmark.1 Greenland, however, has large challenges 
related to adverse childhood experiences, poor mental 
health, obesity, substance misuse and dependence, 
smoking, and suicide.2 These challenges are particularly 
present in the Inuit population,2 which constitute around 
90% of the population.
The Nordic region is known for its relatively rich and 
comparable health data environment; however, broad 
analyses of differences in disease burden between the 
countries are lacking. The aim of the present study was 
to compare life expectancy and disease burden between 
countries and sexes in the Nordic region. Based on data 
from the Global Burden of Disease Study 2017 (GBD 
2017), we explored changes in life expectancy from 
1990 to 2017, and the top ten causes and risk factors for 
disability-adjusted life-years (DALYs) among females and 
males in the Nordic countries and Greenland.
Methods
Overview
GBD analyses adhere to the Guidelines for Accurate 
and Transparent Health Estimates Reporting standards.3 
Detailed descriptions of measures and methods 
employed in the GBD study have been previously 
published.4
GBD has produced disease burden estimates by country 
since GBD 2010, with annual updates since GBD 2015. 
Each cycle includes new data sources and methodological 
advancements, and re-analyses the entire time series of 
results. In GBD 2017, disease burden was estimated for 
282 causes of death, 359 diseases and injuries, and 84 risk 
factors for 195 countries and territories by sex, age, and 
year. Causes and risk factors are structured into four-level 
classification hierarchies, increasing in detail from Level 1 
to Level 4 (appendix p 2). On each level, the causes and 
risk factors are exhaustive and mutually exclusive. In 
this study, the 167 causes and 39 risks at Level 3 in the 
hierarchy were examined.
GBD employs four main measures of disease burden: 
deaths, years of life lost (YLLs), years lived with disability 
(YLDs), and disability-adjusted life-years (DALYs; panel). 
Additionally, the present study includes measures of life 
expectancy.
Data sources
An aim in GBD is to identify and use all available health 
data sources in the analyses. Information on cause 
prevalence and incidence is gathered through systematic 
searches and reviews of published and unpublished 
data. Information about the input data sources can be 
Research in context
Evidence before this study
The Nordic countries—Norway, Sweden, Finland, Iceland, 
and Denmark—rank highly on life expectancy and development 
indices. Previous comparative studies of the Nordic countries 
have observed differences in middle-age mortality, 
cardiovascular diseases, and lung cancer and variations in 
smoking prevalence, alcohol consumption, and alcohol-related 
mortality between these countries. Despite a relatively rich 
health data environment in these countries, broad analyses of 
differences in life expectancy and disease burden between them 
have not been done. The Global Burden of Diseases, Injuries, 
and Risk Factors Study (GBD) has described the contribution of 
fatal and non-fatal causes and risk factors to disease burden in 
different geographical locations, including the Nordic countries. 
However, the Nordic results have been part of the overall 
presentation of results in GBD, and studies focusing specifically 
on life expectancy and disease burden in the Nordic countries 
have been lacking.
Added value of this study
The present study expands on previous single studies in the 
Nordic countries by including non-fatal diseases and a range of 
risk factors, comparing the disease burden impact of 167 causes 
and 39 risk factors using the GBD framework. The results are 
based on data from nearly 4000 sources in the Nordic 
countries, while also incorporating data from elsewhere if 
Nordic data are sparse or absent, ensuring disease burden 
estimates for all causes and risk factors. The standardised data 
management and methods employed in GBD ensure 
comparability of results between diseases and risk factors, 
and across countries and over time. We used the country-
specific estimates of GBD 2017 to compare life expectancy and 
disability-adjusted life-years (DALYs) and the risk factors driving 
the size of these metrics for the Nordic countries. Greenland, 
an autonomous area of Denmark, was analysed as a separate 
location in the GBD study and included in the comparison. 
Sex-specific analyses cover the period from 1990 to 2017. 
The complete overview over the population health in the 
Nordic countries provided by the present study, and the 
evidence of differences and similarities in life expectancy and 
disease burden between them, adds valuable information to 
the details known from previous studies.
Implications of all the available evidence
The Nordic countries have the potential to build on their 
existing strong tradition of collaboration to face both shared 
and country-specific public health challenges. The high disease 
burden due to smoking and alcohol use in Denmark, and alcohol 
use in Finland, implies potential health gains by adopting public 
health strategies from Iceland, Norway, and Sweden. The low 
life expectancy and high disease burden in Greenland compared 
with the rest of the region are striking and require action.
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found in the GBD Global Health Data Exchange (GHDx) 
platform. Data on mortality and causes of death are, for 
the Nordic countries, collected from vital registration 
systems, such as cause of death registries. Deaths with 
unspecified diagnoses or codes that cannot be underlying 
causes of death—so-called garbage codes, such as heart 
failure—are redistributed in GBD to valid death codes 
(eg, for heart failure, to coronary heart disease, atrial 
fibrillation, and other causes) according to algorithms. 
The proportion of redistributed garbage codes toward 
the end of the present study period (2015–16) varied 
from 34% in Greenland to 4% in Finland, with 15–16% 
in Denmark, Norway, and Sweden.5
Disease burden estimation
Cause of Death Ensemble modelling (CODEm) is used 
in GBD to estimate causes of death by age, sex, geography, 
and time.6 Estimates of incidence, prevalence, excess 
mortality, and remission are calculated in DisMod-MR 2.1, 
a Bayesian meta-regression tool.7 Assumed independent 
comorbidity is factored into the estimates. Disability 
weights quantify health loss associated with non-fatal 
causes. They range from 0 (“no health loss”) to 1 (“dead”) 
and are based on the general population’s consideration 
of cause-specific health loss.8
The attributable disease burden from risk factors is 
estimated in three steps. First, meta-analyses of the 
published literature are done to estimate the relative risk 
of non-fatal health loss, mortality, or both, for each risk 
factor–outcome pair. Next, the current distribution of 
exposure to risk factors is estimated by location, sex, and 
age group. Finally, attributable disease burden is estimated 
by comparing the burden due to the current risk factor 
distribution with the hypothetical burden due to the 
theoretical minimum risk exposure level distribution.
Uncertainty analysis
The uncertainty intervals (UIs) of the point estimates 
reflect uncertainty from model specification, stochastic 
variation, and measurement bias. The final published 
GBD estimates and UIs are based on 1000 draws from 
the posterior distribution of estimates.9 The mean of 
the draws defines the point estimate, and the 2·5th and 
97·5th percentiles define the bounds of the 95% UIs.
Analysis presented in this paper
We obtained data from the GBD results tool. Location-
specific estimates were produced in GBD for the Nordic 
countries (Denmark, Finland, Iceland, Norway, and 
Sweden) and the Danish autonomous area of Greenland. 
The Faroe and Åland Islands were included in the Danish 
and Finnish estimates. We examined sex-location-specific 
development in life expectancy by year and percentage 
change between 1990 and 2017 for the Nordic countries 
and Greenland, and compared these with global estimates 
and estimates for the GBD high-income super-region 
(ie, western Europe, southern Latin America, high-income 
countries in North America and Asia Pacific, 
and Australasia) and the Nordic region. The Nordic 
regional estimates are the overall estimates for the Nordic 
countries and for Greenland. We identified and compared 
the ten Level 3 causes contributing the highest age-
standardised rates of YLLs, YLDs, and DALYs per 
100 000 population by sex, and the ten most important 
risk factors for DALYs. Location-specific point estimates 
outside the UIs of the Nordic regional estimates were 
interpreted as different from the regional estimate. We 
calculated the proportional difference between the 
location-specific and the Nordic regional point estimates 
for the top ten causes and risk factors. Finally, we 
calculated the percentage of the total number of DALYs 
attributable to the risk factors included in GBD.
Role of the funding source
The funders had no role in study design, data collection, 
data analysis, data interpretation, or report writing. All 
authors had full access to all data. The corresponding 
author had final responsibility to submit the manuscript 
for publication.
Results
Life expectancy at birth increased for both sexes in all 
areas of the Nordic region between 1990 and 2017 
For the Global Health Data 
Exchange see http://ghdx.
healthdata.org
For the GBD results tool see 
http://ghdx.healthdata.org/gbd-
results-tool
Panel: Measures of disease burden in the Global Burden of 
Diseases, Injuries, and Risk Factors Study included in the 
current study
Life expectancy
Life expectancy at birth is the number of years a person in 
a given location can expect to live, given the observed 
age-specific mortality rates remain constant.
YLL
The YLL is a measure of mortality, quantified as the remaining 
life expectancy at age of death for a specific cause in a given 
location. For this measure, life expectancy is defined as the 
maximum attainable life expectancy, based on a standard life 
table of the lowest observed death rates in 5-year intervals in 
populations above 5 million. The same reference is used for 
both males and females.
YLD
The YLD is a measure of non-fatal health loss. It is estimated 
by multiplying prevalence of a disease or injury with the 
associated health loss, quantified by disability weights.
DALY
The DALY measure indicates the difference between the 
current health state of a population and an ideal situation 
where everyone lives to maximum attainable life expectancy 
in full health. DALYs are the sum of mortality (YLLs) and 
non-fatal health loss (YLDs) in the population.
YLL=year of life lost. YLD=year lived with disability. DALY=disability-adjusted life-year.
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Figure 1: Life expectancy at birth by sex in the years 1990, 2000, 2010, and 2017
The shaded areas around the lines indicate 95% uncertainty intervals.
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(95% UI)
Percentage of total 
DALYs due to YLLs
All-cause age-standardised DALY rate 
(95% UI)
Percentage of total 
DALYs due to YLLs
Global 29 934·6 (26 981·9–33 211·2) 60·4% 35 834·3 (33 218·2–38 740·7) 70·5%
High income 18 678·8 (15 790·6–22 022·9) 44·4% 22 044·2 (19 487·1–24 983·3) 57·2%
Nordic region 17 762·2 (14 873·2–21 228·4) 43·4% 19 932·7 (17 281·4–22 954·3) 53·9%
Denmark 18 330·9 (15 503·9–21 650·3) 46·7% 20 696·0 (17 964·2–23 821·3) 56·3%
Finland 17 524·3 (14 522·1–20 886·8) 43·6% 21 776·2 (19 010·9–24 970·2) 57·0%
Greenland 26 666·6 (23 478·4–30 218·8) 52·6% 33 101·4 (30 182·3–36 218·6) 68·8%
Iceland 16 074·1 (13 216·4–19 240·8) 35·5% 19 417·3 (16 828·9–22 390·5) 52·1%
Norway 17 794·2 (14 811·1–21 288·1) 40·4% 19 646·9 (16 916·5–22 733·0) 49·4%
Sweden 17 563·1 (14 584·4–20 977·3) 42·9% 18 555·7 (15 968·6–21 426·8) 52·5%
DALY=disability-adjusted life-year. UI=uncertainty interval. YLL=year of life lost.
Table: Age-standardised rates of all-cause DALYs, with percentage of total DALYs due to YLLs
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(figure 1; appendix p 3). Over the period, males in the 
Nordic region had 0·5–0·6 years longer life expectancy 
than males in the high-income region, whereas life 
expectancy among Nordic females was similar to those 
in the high-income region. In 1990, males in the Nordic 
region had 10·0 years longer life expectancy than the 
global estimate and females had 11·5 years longer life 
expectancy. This gap reduced to 9·3 years for males and 
8·3 years for females in 2017.
The difference in male life expectancy among Nordic 
countries reduced between 1990 and 2017 (figure 1; 
appendix p 3). In 1990, the gap between the highest 
(Iceland) and lowest (Finland) life expectancies was 
4·6 years. This dropped to 2·2 years in 2017 (Sweden vs 
Finland). Between-country differ ences increased slightly 
among females over the same period, from 2·7 years 
between Sweden and Denmark in 1990 to 3·2 years 
between Iceland and Denmark in 2017. Among Nordic 
countries, Finnish males and Icelandic females im proved 
their life expectancy the most during the studied period 
(appendix p 3). In the autonomous area of Greenland, life 
expec tancy increased by 8·2 years for females and 8·7 years 
for males between 1990 and 2017, representing the highest 
increase in the Nordic region overall. In the Nordic 
countries, the lowest country-specific life expectancies in 
2017 were found for males in Denmark (78·8 years, 95% UI 
Figure 2: Age-standardised DALY rates per 100 000 by sex for the top ten Level 3 causes in the Nordic countries in 2017, and difference from the Nordic region estimate
Difference is expressed as proportional difference—eg, a difference of 1·17 indicates that the rate is 17% higher compared with the Nordic region estimate. Bold differences indicate that the country-specific 
point estimate is outside the 95% uncertainty interval of the Nordic region estimate. Anxiety=anxiety disorders. Alcohol=alcohol use disorders. Alzheimer’s=Alzheimer’s disease and other dementias. 
COPD=chronic obstructive pulmonary disease. Depression=depressive disorders. Drugs=drug use disorders. Headaches=headache disorders. Lung cancer=tracheal, bronchus, and lung cancer. 
Neonatal=neonatal disorders. DALY=disability-adjusted life-year.
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78·1–79·5) and Finland (78·6 years, 77·8–79·2) and females 
in Denmark (82·7 years, 81·9–83·4). Greenland had 
shorter life expectancy than Denmark in 2017, with a gap of 
8·0 years for males and 5·5 years for females. Life 
expectancy in Greenland was more similar to the global 
estimates than to the Nordic or high-income estimates 
across the years studied. Sex differences generally reduced 
over the period; however, a stagnation in life expectancy 
among males from 2010 to 2017 led to an increased sex 
difference in Iceland (figure 1). Finland had the largest 
sex difference across the period, calculated as the average 
difference for each country across the GBD years studied.
In 2017, Nordic males had 44% fewer DALYs than 
males globally, whereas females had 41% fewer than 
females globally in 2017 (table). YLLs also contributed 
less to the total number of DALYs in the Nordic region 
than in the high-income region and globally. However, 
there were sex differences: more than half (53·9%) of the 
total number of DALYs among males in the Nordic 
region were due to YLLs, compared with 43·4% among 
females. All-cause DALY rates did not differ much 
between the Nordic countries; however, they were 
substantially higher among males and females in 
Greenland (table). Overall, all-cause DALY rates were 
higher among males than among females. The top ten 
causes of YLLs and YLDs are presented in the appendix 
(pp 4–7). Age-standardised rates with 95% UIs for DALYs 
are given in the appendix (pp 8–9).
The leading causes of DALYs in the Nordic region 
differed by sex (figure 2; appendix pp 8–9). Causes that 
largely contribute to DALYs through YLLs (such as 
ischaemic heart disease, stroke, lung cancer, diabetes, 
and chronic obstructive pulmonary disease [COPD]), as 
well as alcohol and drug use disorders and injuries 
(ie, falls and self-harm), ranked higher among males 
than females (appendix pp 4–5). Causes related to 
YLDs (such as headaches, anxiety disorders, depressive 
disorders, and low back and neck pain) made up a larger 
proportion of the DALYs among females (figure 2; 
appendix pp 6–7). Ischaemic heart disease and low back 
pain were the leading two causes of DALYs among males, 
whereas low back pain and headaches were the 
two leading causes among females.
Most country-specific estimates of DALYs were within 
the UIs of the Nordic regional estimates (figure 2; 
appendix pp 8–9). In Greenland, however, higher DALY 
rates than the regional estimates were found for most of 
the ten leading causes, with the largest difference found 
for self-harm. Region–country differences were primarily 
found for causes of YLLs (appendix pp 4–5). Among the 
Nordic countries, ischaemic heart disease had high 
country-specific DALY estimates in Finland, for Swedish 
females, and Icelandic males, and low estimates in 
Norway, Denmark, and among Icelandic females 
(figure 2). Denmark and Iceland had high DALY rates for 
lung cancer across both sexes. DALY rates due to COPD 
were high among females in Iceland and both sexes in 
Denmark. More disease burden was attributed to alcohol 
use disorders among Danish and Finnish males than 
their neighbours. Self-harm ranked among the top 
ten causes of DALYs for males in all countries but 
Denmark. Self-harm rates were particularly high in 
Finland and Greenland—for the latter, rates were 
five times higher than the regional estimates for both 
males and females (figure 2). In the Nordic countries, 
among the causes that primarily contribute to YLDs, 
only anxiety disorders among Norwegian females and 
neonatal disorders among Finnish males and females 
differed from the regional estimate (figure 2; appendix 
pp 6–7).
Among the Nordic countries, the proportion of DALYs 
attributable to the GBD risk factors in 2017 was higher 
in males (country range 41·4–49·0%) than females 
(31·6–39·6%; appendix pp 10–11). There were few 
differences in the top ten ranking of risk factors (figure 3; 
appendix pp 12–13). Males and females in Greenland had 
higher rates than the regional estimates for most of these 
risk factors. Smoking ranked as the top risk factor for 
both males and females in all countries, except for males 
in Sweden (second) and for both sexes in Finland 
(fourth). Males and females in Denmark had around 
40% more DAYs due to smoking than the regional 
estimate, and Greenland had almost three times more 
than the regional estimate. Alcohol use was among the 
top ten risk factors for both sexes in all countries, as was 
drug use except for Danish and Swedish females. Among 
the Nordic countries, DALYs attributable to alcohol use 
were particularly high among males in Finland and 
Denmark. The metabolic risk factors (ie, high fasting 
plasma glucose, high systolic blood pressure, high body-
mass index, and high LDL cholesterol) ranked among the 
top six risk factors in all the Nordic countries and for 
both sexes, except for high LDL cholesterol, which ranked 
eighth among Danish females. Most country estimates 
for these risk factors differed little from the Nordic 
regional estimates; exceptions were high systolic blood 
pressure, which was higher among both sexes in Finland 
and lower among Icelandic females and Norwegian 
males, and high LDL cholesterol, which was higher 
among Finnish males and lower among Danish males. 
Figure 3: Age-standardised DALY rates per 100 000 by sex for the top 
ten Level 3 risk factors in the Nordic countries in 2017 and difference from 
the Nordic region estimate
Difference is expressed as proportional difference—eg, a difference of 
1·43 indicates that the rate is 43% higher compared with the Nordic region 
estimate. Bold differences indicate that the country-specific point estimate is 
outside the 95% uncertainty interval of the Nordic regional estimate. 
Birthweight and gestation=low birthweight and short gestation. 
BMI=body-mass index. High blood pressure=high systolic blood pressure. 
High glucose=high fasting plasma glucose. High processed meat=diet high in 
processed meat. Impaired kidney=impaired kidney function. Low fruits=diet low 
in fruits. Low nuts and seeds=diet low in nuts and seeds. Low whole grains=diet 
low in whole grains. Occupational ergonomic=occupational ergonomic factors. 
DALY=disability-adjusted life-year.
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Dietary factors were generally more important for male 
than female disease burden (figure 3).
Discussion
Compared with global estimates, both sexes had higher 
life expectancy and lower overall disease burden in 
terms of age-standardised DALYs in the Nordic region. 
Premature mortality (YLLs) was less important for the 
overall disease burden in the Nordic region than globally, 
and among Nordic females compared with males. The 
overall disease burden did not differ substantially 
between the Nordic countries, but some differences were 
found for life expectancy, which was lower for both sexes 
in Denmark and for males in Finland. Most of the top ten 
causes of disease burden among males were related to 
mortality (YLLs), whereas causes related to disability 
(YLDs) were ranked higher as causes of disease burden 
among females. Sex-specific country variation was 
mainly observed for causes contributing to disease 
burden primarily through YLLs. Alcohol-attributable 
disease burden was higher among males in Denmark 
and Finland than in the other Nordic countries, as was 
disease burden attributable to smoking in Denmark. 
Males and females in Greenland had substantially lower 
life expectancy and higher all-cause DALY rates than the 
Nordic countries.
The country variations identified in our study were 
in line with previous studies focusing on differences 
between the Nordic countries in smoking prevalence10 and 
smoking-related mortality,11 alcohol consumption12 and 
alcohol-related mortality,11,13,14 middle-aged mortality,15 
and cause-specific mortality.15 By comparing 167 Level 3 
causes and 39 Level 3 risk factors in a single analytic 
framework, the GBD results expand the knowledge from 
previous single studies. The inclusion of sex-specific 
and country-specific drivers for non-fatal diseases is 
important for benchmarking and comparative analyses in 
the Nordic region. The results suggest that the individual 
countries face both common and specific challenges in 
reducing disease burden.
Life expectancy became more similar between the 
Nordic countries from 1990 to 2017. The general increase 
was stronger in the first half of this period than the second 
half. This trend is in line with findings from other 
countries and periods; rapid progress in some periods is 
often followed by a slower rise.16 After World War 2, and 
particularly after the 1970s, the Nordic countries had a 
faster growth in welfare, living standards, and health care 
than most other countries in the world. For long periods 
in the post-war era, Iceland, Sweden, and Norway had the 
highest life expectancy in global comparisons. However, 
other countries in other regions have caught up with the 
Nordic countries in economic, social, and cultural 
modernisation, and are now in many cases exceeding the 
Nordic countries in life expectancy ranking. A complex 
interplay of factors could explain why the Nordic countries 
have had a relative decline in life expectancy rank. 
One factor might be that other countries have had more 
success in improving mortality in older ages.17 As the vast 
majority of deaths in the Nordic countries happens after 
age 65 years, future studies should compare the 
development in causes related to death in older age to 
identify whether the Nordic countries are less successful 
in reducing these than countries that have surpassed the 
life expectancies in Nordic countries.
Another factor for why the Nordic countries are losing 
ground in life expectancy rankings might relate to what 
is often termed the Nordic paradox. This term refers to 
the observation that despite the low income inequalities, 
free access to education and health services, and 
generous welfare policies that characterise Nordic 
countries, gaps in life expectancy by socioeconomic 
status are larger in the Nordic welfare states than in 
many less egalitarian societies.18 Furthermore, this gap 
seems to have increased over the past few decades.19 This 
suggests that at least part of the slowing in improvement 
of life expectancy in the Nordic countries could be due to 
a stagnation in life expectancy among those with low 
socioeconomic status. This should be a common cause 
for concern, which could be addressed collectively and in 
joint effort by all Nordic countries.
Cardiovascular diseases and cancers were important 
causes of DALYs in all countries studied, illustrating the 
need for a continued focus on prevention and treatment 
of these diseases. Smoking is responsible for an 
estimated 16·4% of the cardiovascular burden and 
23·7% of the cancer burden in the Nordic region (data 
not shown). Smoking-attributable disease burden did, 
however, vary between countries, with the Danes, and in 
particular Danish females, experiencing a much higher 
disease burden due to smoking than the other countries. 
It is likely that these country differences are related 
to differences in smoking policies and culture. For 
instance, Norway has had strict tobacco legislation 
for decades. The widespread and longstanding use of 
snus as a tobacco alternative in Sweden might have 
contributed to the lower smoking-related disease burden 
in this country, as snus is not captured within GBD 
tobacco use estimates.20 By comparison, Denmark has a 
shorter history of tobacco control21 and might therefore 
have a larger potential to reduce its smoking-related 
disease burden by adopting its Nordic neighbours’ 
policies. Denmark, Norway, Iceland, and Sweden were 
among the 13 countries globally experiencing the 
largest declines in smoking prevalence between 1990 
and 2015.22 Smoking is also much less common in 
younger generations,23 although a high level of smoking 
across the region among young women in lower socio-
economic positions is a challenge. Despite this, a high 
smoking-attributable disease burden in the Nordic 
region is still to be expected due to population growth 
and ageing. However, if the Nordic countries continue 
their success in smoking cessation and prevention of 
young people starting smoking, the disease burden 
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attributed to smoking could reduce in the coming 
decades.
Alcohol use ranked highly among risk factors. It was 
the leading risk factor among males in Finland and 
ranked third among Danish males. Overall alcohol 
consumption levels in these two countries are similar,24 
but consumption of stronger alcohol is higher in Finland 
than in Denmark.24 Sex differences in DALYs attributed to 
alcohol use were also larger in Finland than in Denmark. 
These results are in line with previous GBD publications.25 
Alcohol policies differ somewhat between the Nordic 
countries, which might contribute to differ ences in 
alcohol consumption and disease burden. Iceland, 
Sweden, Norway, and Finland have historically had 
restrictive alcohol policies, mainly through strict 
regulation of alcohol sales, advertisement, age limits for 
purchasing, pricing, and taxation.24 In the mid-1990s, the 
Nordic countries had to adapt their alcohol polices to the 
framework of the EU and the European Economic Area. 
Being outside of the EU, Iceland and Norway were able to 
maintain a stricter alcohol policy than the other Nordic 
countries. Alcohol policies were liberalised in Finland, 
Sweden, and Denmark, and in 2004, alcohol prices were 
also reduced in Finland. Geography might also influence 
access to these substances, and imported alcohol for 
personal use can vary by proximity to and trade regulation 
with countries with more affordable alcohol products. For 
instance, traveller quotas for alcohol imports from 
Estonia, bordering Finland, were abolished when Estonia 
joined the EU in 2004. Together with the reduction of 
alcohol prices seen the same year, this led to an increase 
in consumption and mortality rates from alcohol-related 
causes such as liver cirrhosis and injuries in Finland.26 
Nevertheless, men and women in the same country share 
policy context. The observed sex differences in alcohol-
attributable disease burden within the Nordic countries, 
and in Finland particularly, implies that cultural, social, 
and gender-specific factors are also involved, adding to 
the ongoing debate on the effects of alcohol policies.11
In terms of dietary risk, the Nordic countries face many 
of the same challenges as seen globally.27 A healthy diet is 
not only about avoiding what is deemed bad, but also 
replacing this with intake of what is deemed good. 
In 2006, the Nordic Council of Ministers launched an 
action plan for heathier diets in the Nordic countries. 
Many of the interventions suggested in this plan targeted 
consumers. However, current expert recommendations 
for improving population diet point further upstream, 
targeting the food industry and systems for food access.27 
Country-specific interventions in the Nordic region 
include access to nutritional food in institutions such as 
schools and hospitals, food product labelling, pricing, 
and taxation, as well as collaboration with the food 
industry in terms of the composition of ingredients in 
its products. A renewed comparative focus on these 
interventions could help the Nordic countries to learn 
from each other to improve the population’s diet.
Headache, musculoskeletal disorders, and mental 
disorders were important causes of non-fatal disease 
burden across the countries, and entail major economic 
consequences for society through work absence and 
health-service use. Back pain, neck pain, anxiety 
disorders, and depressive disorders are large contributors 
to disease burden, particularly in the working-age 
population (aged 15–67 years), despite no mortality 
attributed to these causes. Compared with causes with 
a large mortality component, effective prevention of 
disease burden by reducing causes of disability is less 
well established. This is mirrored in GBD, because only 
fractions of the disease burden from these causes are 
assigned risk factors; for example, the risk factors 
included in GBD explain 94·9% of the DALYs attributed 
to ischaemic heart disease. In GBD 2017, bullying victi-
misation was introduced as a risk factor for anxiety and 
depressive disorders, accounting for 1·7% and 3·1%, 
respectively, of their disease burden in the Nordic region. 
Implementation and improvement of anti-bullying 
interventions is thus one identified potential strategy for 
reducing disease burden from mental disorders. Beyond 
better identi fication of modifiable risk factors for 
prevention, tools to reduce severity levels and the 
personal, social, and economic consequences associated 
with important non-fatal causes of disease burden seem 
warranted.
Denmark has specific public health challenges 
compared with the other Nordic countries. A range of 
publications have pointed at probable causes of the 
poorer population health in Denmark, and higher rates 
of smoking and alcohol use have been particularly 
emphasised. Despite the alarming estimates of alcohol 
and tobacco use in Denmark, access to these products 
remains liberal. For instance, a WHO report21 in 2018 
noted that Denmark had no overall strategy or plan to 
protect children, adolescents, and adults from the harms 
of tobacco; that tobacco was both affordable and 
promoted at sales points; and that the tobacco industry 
was influential in Danish policy making. The experience 
from Denmark indicates that information alone might 
not be sufficient to markedly change health behaviour, 
and that targeted political efforts is often necessary to be 
able to change risk factor and disease burden patterns in 
the population.
The disease burden profile in Greenland stands in sharp 
contrast to that of the Nordic countries. Bjerregaard and 
Larsen2 have highlighted three main determinants of the 
problematic health conditions in Greenland: adverse 
childhood conditions, obesity, and smoking. Additionally, 
the GBD data highlight alcohol and drug use and metabolic 
factors. Greenland has poorer socioeconomic conditions 
than the Nordic countries, and faces a social transition 
with important changes in lifestyle and employment. 
Additionally, the traditional fishing and hunting lifestyle 
implies a higher risk of accidents, and availability of guns 
might contribute to high rates of suicide and homicide by 
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firearm (data not shown). Similar problems have been 
described from other Inuit populations—eg, in Canada.28
The key strength of GBD is the standardised data 
management and methods to make results comparable. 
In terms of limitations, this study shares those of GBD 
more generally, which are described in the capstone 
papers. The key limitation for the present purpose is the 
large spread in the quality of the underlying data between 
estimates of life expectancy and causes of death, and 
estimates of non-fatal and risk factor-attributed disease 
burden. GBD provides results for all included risks, 
diseases, and injuries even when data are sparse. This 
ensures estimates for each cause and risk factor, but 
requires caution when interpreting and using the results. 
For non-fatal causes of disease burden, underlying 
data sources are sparser and more heterogeneous 
than mortality sources, and comparisons of non-fatal 
estimates between countries are further hampered by the 
lack of information on severity of disease, which makes it 
difficult to account for differences in quality and access 
to treatment. Despite these shortcomings, GBD provides 
the by far most compre hensive and reliable framework 
for comparisons of non-fatal health outcomes between 
countries. For mortality data, the Nordic countries 
have high-quality, continuously updated cause of death 
registries. GBD data are similar to the national statistics 
for life expectancy and overall mortality estimates. Thus, 
the use of GBD data for these measures might not 
represent any particular advantage from the official, 
national statistics of the Nordic countries. For cause of 
death data, however, there are several advantages of 
using model-based GBD data instead of direct 
comparisons of national statistics, as the GBD models 
account for idiosyncratic and system-adapted differences 
in national data over time and between countries, and 
ensure that all garbage codes are redistributed in a 
standardised way. This ensures that the GBD results are 
internally comparable,5 but comparisons with national 
mortality statistics for causes where garbage code redis-
tribution is extensive will reveal discrepancies. One such 
example is Greenland, which had a higher proportion of 
garbage codes than the Nordic countries. Redistribution 
of garbage codes in Greenland will not affect life 
expectancy and all-cause mortality estimates in this 
location, but can affect the resulting distribution of 
causes of death.
Despite the need for better and more updated data on 
non-fatal diseases and risk factors, the availability of high-
quality data is better in the Nordic countries than in many 
other regions in the world. As data sources are generally 
similarly organised in the Nordic countries, cross-country 
comparisons should be reasonably reliable in the Nordic 
region. Comparisons between GBD estimates and 
national vital statistics from the Nordic countries might 
also help to adjust and improve the GBD models, which 
will also be useful for improving estimates from regions 
of the world with poorer data.
The life expectancy and disease burden in the Nordic 
region share common patterns, but with several important 
differences between the countries and the sexes. 
Greenland has a disease burden profile in sharp contrast 
to the Nordic countries. Comparisons between the Nordic 
countries illustrate how disease burden can vary despite 
similar geographical and income settings and comparable 
access to universal health and welfare services, but 
with cultural and lifestyle differences. The observations 
suggest a potential for reduced disease burden through 
adopting evidence-based policies and programmes from 
neighbouring countries with lower disease burden.
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